Oxford Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Oxford Asset Management’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,799	Closed	-$498K	–	2151
2019 Q3	$498K	Sell	4,799 -844	-15%	-$79.7K	0.01%	1265
2019 Q2	$523K	Buy	5,643 +2,932	+108%	+$204K	0.01%	1259
2019 Q1	$248K	Sell	2,711 -3,951	-59%	-$275K	0.01%	1456
2018 Q4	$371K	Buy	6,662 +2,307	+53%	+$175K	0.01%	1315
2018 Q3	$519K	Sell	4,355 -341	-7%	-$39.6K	0.01%	1300
2018 Q2	$480K	Buy	+4,696	New	+$582K	0.01%	1359

Other funds holding SYRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Oxford Asset Management's SYRS Position: Q4 2019 in Review

Oxford Asset Management sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q4 2019, closing a stake of 4,799 shares — an estimated $498K sold.

Oxford Asset Management first reported a position in SYRS in Q2 2018 and held it in 6 quarters. The position peaked at $523K in Q2 2019. 70 funds tracked by Wall St. Rank hold SYRS as of Q4 2019.

Oxford Asset Management reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Oxford Asset Management sold 4,799 Syros Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $498K.
Oxford Asset Management first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
Oxford Asset Management's Syros Pharmaceuticals, Inc. Common Stock position peaked at $523K in Q2 2019.
70 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.